AI Clinical Trial Matching for Colorectal Cancer
Second Look Cancer combines structured patient details with trial-level review so patients can focus on realistic options faster.
Why matching quality matters
Most public trial search tools return long lists with little explanation. Second Look Cancer is designed to reduce noise by structuring the profile details that actually shape trial fit.
Instead of making patients scan raw registry text alone, the platform helps translate biomarker status, treatment history, and geography into a more actionable shortlist.
What the product is trying to solve
Patients are often forced to choose between a comprehensive registry and a readable experience. Second Look Cancer aims to keep the breadth of public trial data while making it easier to interpret.
That means clearer summaries, more consistent filters, and a better handoff to the conversations patients need to have with their oncologist or trial site.
Related reading
AI Trial Matching
How patient data becomes a more useful trial shortlist.
Biomarker-Based Trial Search
Why biomarkers matter and how to search more effectively.
Plain-Language Trial Summaries
A patient-first way to understand trial records.
Second Look Cancer vs ClinicalTrials.gov
A comparison of raw registry search vs patient-first review.